butorphanol vs nalbuphine
Side-by-side comparison of butorphanol and nalbuphine Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Stadol
Nubain
Butorphanol nasal spray is a strong pain medicine. It is used when other pain medicines are not strong enough or cannot be tolerated.
Nalbuphine injection is a strong pain medicine. It is used when other pain treatments don't work well enough.
This medicine treats severe pain that requires an opioid pain reliever. It is for use when other pain treatments are not strong enough or cannot be tolerated. Do not use this medicine for a long time unless your pain is still severe and other treatments are still not adequate.
Nalbuphine injection is used to manage severe pain that requires a strong opioid medicine. It can also be used before and after surgery to help with pain. It can also be used during labor and delivery for pain relief.
Butorphanol is an opioid agonist-antagonist. It works by changing how your brain and nervous system respond to pain. It attaches to certain receptors in the brain to reduce pain signals.
Nalbuphine works by attaching to opioid receptors in the brain and spinal cord. These receptors help to block pain signals. Nalbuphine both activates and blocks opioid receptors.
- • Sleepiness
- • Dizziness
- • Nausea
- • Vomiting
- • Nasal congestion
- • Feeling sleepy
- • Sweaty or clammy skin
- • Nausea
- • Vomiting
- • Dizziness
- Allergic reaction to the drug 48
- Drug not working 45
- Missed dose 36
- Feeling sick to your stomach 25
- Head pain 16
- Allergic reaction to the medicine 36
- Using the medicine for a purpose it was not approved for 16
- The medicine is not working 11
- Baby exposed to the medicine during pregnancy 10
- Newborn has trouble breathing 10
This medicine has serious warnings. It can cause addiction, abuse, and misuse, which can lead to overdose and death. It can also cause life-threatening breathing problems, especially when you first start using it or after a dose increase. Accidental use, even one dose, can cause a fatal overdose, especially in children. Using this medicine with benzodiazepines or other drugs that can make you sleepy, including alcohol, can cause serious problems, including coma and death. If you use this medicine for a long time during pregnancy, it can cause withdrawal symptoms in the newborn that could be life-threatening if not treated.
Nalbuphine can cause serious breathing problems that can be life-threatening, especially when you first start taking it or after a dose increase. Taking nalbuphine with benzodiazepines (like anxiety or sleep medicines) or other drugs that can make you sleepy, including alcohol, can cause very serious sleepiness, breathing problems, coma, and death.
If you need to use this medicine for a long time during pregnancy, it can cause withdrawal symptoms in your newborn. Make sure a newborn specialist is available when you deliver your baby.
Using nalbuphine during pregnancy may cause breathing problems in the newborn. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if nalbuphine passes into breast milk. Talk to your doctor about the risks and benefits of breastfeeding.
How to Read This butorphanol vs nalbuphine Comparison
butorphanol is classified in the Opioid Agonist-Antagonist drug class, while nalbuphine sits within the Opioid Agonist-Antagonist class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, butorphanol has 170 submissions while nalbuphine has 83. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between butorphanol and nalbuphine — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.